News Story #19393
New Products and Aggressive Initiatives Help Reference and Specialty Labs Boost Revenues
Read MorePosted by Clinical Lab Products | Apr 1, 2004 | Cancer, Miscellaneous |
New Products and Aggressive Initiatives Help Reference and Specialty Labs Boost Revenues
Read MorePosted by Clinical Lab Products | Mar 10, 2004 | Miscellaneous |
Dade Behring Signs Manufacturing Licensing Agreement for FSAP Dade Behring and Aventis Behring LLC have signed a license agreement that provides Dade Behring with worldwide in vitro diagnostic rights to any Aventis Behring inventions that relate t
Read MorePosted by Clinical Lab Products | Mar 4, 2004 | Cerebrovascular, Miscellaneous |
Biomarkers at Bedside: i-STAT’s Point-of-Care Test Produces Cardiac Biomarker Troponin Results Withs
Read MorePosted by Clinical Lab Products | Mar 1, 2004 | Miscellaneous |
By Marleen and Gary Wolfe The basic theory underlying the physicians office laboratory (POL) is deceptively simple: If physicians can run certain critical assays on patients while they are in the office, the patients can be diagnosed and tr
Read MorePosted by Clinical Lab Products | Feb 10, 2004 | Cancer, Miscellaneous |
Pall Ultrafiltration Technology Simplifies Production of Vaccines Conjugate vaccines that protect infants and young children from infectious diseases will become more widely available now that the complicated and expensive production process has b
Read More